LearnSkin ads

Alopecia areata research and treatment options are evolving fast — and we’re breaking it all down for you! 🔬✨ Join us Tuesday, December 16 at 5 PM PST for a one-hour masterclass connecting immune pathways, emerging therapies, and real patient-centered care. 🎁 Attend live and receive a $20 gift card! Be among the first 99 HCP attendees to complete the masterclass to receive a gift card from LearnSkin. (Offer limited to U.S. HCPs with a valid NPI.) Here’s what you’ll learn: ✔️ How to assess disease mechanisms ✔️ The latest on emerging treatments ✔️ Tools to support patients with clear, empathetic communication Reserve your spot now and don’t miss this session! 🚀 👉 https://lnkd.in/gyxrsGNA #Dermatology #AlopeciaAreata #JAKInhibitors #Biologics #DermEducation #skinhealth

🔥 Uncover the Common Thread in Chronic Skin Diseases 🔥 Join experts Raj Chovatiya, MD, PhD, MSCI; Jason Hawkes, MD, MS; and Erin Barrett, MD, at the educational ADVENT LearnSkin 2025 Cross-Dermatology Webinar, where they will explore the clinical similarities and differences among AD, BP, CSU, and PN. The discussion will highlight the significance of type 2 inflammation as a common thread in the signs and symptoms of these conditions, as well as the shared and unique inflammatory pathways underlying their pathophysiology. 📅 Date: Tuesday, December 9, 2025 ⏰ Time: 5:00–6:00 PM PST In this live Non-CME masterclass, you’ll gain: ✔️ Understand the clinical similarities and differences in AD, BP, CSU, and PN ✔️ Describe the significance of type 2 inflammation in underlying the clinical signs and symptoms of AD, PN, CSU, and BP ✔️ Highlight shared and unique type 2 inflammatory pathways in the pathophysiology of these chronic inflammatory dermatologic conditions 🔗 Register here: https://lnkd.in/gyxrsGNA #DermatologyCare #SkinHealth #DermatologyEducation #MedicalDermatology #ChronicSkin #Type2Inflammation

Last webinar in the series — don’t miss it! ⛔️ This session will be live only, and no recording will be available afterward. ⛔️ Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases. 📅 Date: December 2, 2025 ⏰ Time: 5:00–6:00 PM PST 🎁 Bonus: Attend live and receive a $15 Amazon gift card from LearnSkin! Register Here: https://lnkd.in/gyxrsGNA This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for Use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

🧠 Bridging Science and Care: Optimizing Management of Alopecia Areata Join us for an expert-led webinar exploring alopecia areata (AA) from mechanism to management. Gain insights into immune drivers, clinical presentations, and practical, patient-centered approaches that can improve outcomes and quality of life. 📅 Tuesday, November 11, 2025 🕔 5:00 PM – 6:00 PM PT Learning Objectives: Recognize how the immune-mediated mechanisms of alopecia areata drive its presentation and progression Understand the myriad nature of presentation and burden for patients with AA Explore how comprehensive approaches to care can support optimized patient outcomes 👉 Don’t miss this opportunity to enhance your understanding of AA and elevate your clinical practice. 🔗 Reserve your spot now and take your AA care to the next level: https://lnkd.in/gyxrsGNA #Dermatology #CME #PatientOutcomes #LearnSkinLive #DermEd #AlopeciaAreata #learnskin

🌐 Explore EBGLYSS® (lebrikizumab-lbkz) Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.EBGLYSS can leave a lasting impression. 📅 Date: November 4, 2025 ⏰ Time: 5:00–6:00 PM PST 🎁 Attend live to receive a $15 Amazon gift card from LearnSkin! This webinar is live only — no recording will be available afterward. Reserve your spot now! https://lnkd.in/gyxrsGNA This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for Use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

🌐 Explore EBGLYSS® (lebrikizumab-lbkz) Join us for "Explore EBGLYSS® (lebrikizumab-lbkz)", an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and real-world experience from patient cases.EBGLYSS can leave a lasting impression. 📅 Date: November 4, 2025 ⏰ Time: 5:00–6:00 PM PST 🎁 Attend live to receive a $15 Amazon gift card from LearnSkin! This webinar is live only — no recording will be available afterward. Reserve your spot now! https://lnkd.in/gyxrsGNA This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for Use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.